Chronic Lymphocytic Leukemia Defeated With PH Balance and Nutritional Therapy

As a person diagnosed with CLL (chronic lymphocytic leukemia) since 2001, I’ve had my eyes trained on Google Alerts and on the web in general, regularly looking for breakthroughs, both conventionally and in the alternative medicine arena. Many people who are diagnosed with CLL are told to hold off on any treatment, as the disease often progresses slowly, and any improvement with treatment is not permanent. Worse yet, the course and aggressiveness of the disease can change at any time. Patients are told to “watch and wait.” This is not a happy way to live.

No role models. The sad truth is that, until this past January 2009, I could find no reference (not one) of any person who was cured of CLL through any kind of traditional medical — or alternative — therapy. The only exception are those who have been cured by way of a bone marrow transplant (BMT). Unfortunately, many people do not survive the procedure. It is extremely risky. Worse yet, a patient can survive the BMT and still have CLL, or develop CLL again at a later date.

The five-year time-line. Despite all the research and trials, there is still no conventionally-sanctioned therapy (chemotherapy, radiation, immunotherapy, etc.), short of BMT, that can effect a cure. Doctors give patients the hope for a complete remission of five years with some of the available therapies. Not all patients achieve complete remission in the first round of chemotherapy. And the chance of success, measured by five-year survival, decreases with each new form of conventional therapy. Not an encouraging picture. This situation has been evident to me since 2001, when I was forty-six and first diagnosed. Who wants to hear about a five-year life plan when you’re forty-six? Not me! While there have been some promising conventional “breakthroughs,” the survival rate remains pretty much the same today.

The search for an alternative. My search for an alternative treatment, or treatment protocol, has been equally difficult. I have been able to find testimony on the web of leukemia patients who have become cancer-free (acute myelogenous leukemia or acute lymphocytic leukemia), but no such luck for CLL. At best, there were stories of people who had held off their CLL with the controversial laetrile (apricot seed extract). But no one with CLL had become cancer free. I was discouraged, but I never gave up the search, or my attempt to discover a blueprint to good health.

The 2009 breakthrough. In January of this year, my Google Alerts revealed an article written by Steve Freier, a man with CLL who recovered to full cancer-free health. He regained his health by having his root canals removed and also by taking coral calcium. Because of his experience, I am in the process now of having all my mercury amalgams replaced with safer porcelain fillings. To find information about his recovery, type “Steve Freier” and “CLL” into Google.

Breakthrough #2. In April 2009, while searching for information about infrared saunas and its effect on leukemia, my husband came across this website: http://www.CLLDefeated.com. It is the story of Hessel Baartse, of Adelaide, Australia. He has totally defeated his CLL by means of removing his root canals and mercury amalgams, and by drastically altering his diet and supplementation, with a concentration on restoring his pH levels to a healthy balance. He credits his dentist, www.ericdavisdental.com for his complete recovery.

There are finally role models for CLL recovery. What used to be a complete mystery now is a challenge with a blueprint for success. There are now at least two cases of men who have beat the odds and defeated their CLL by means of mercury amalgam and root canal removal, nutritional therapy, and pH balance. The further good news is that this program is likely a blueprint to health for people with many other chronic health issues, including cancers.

The future. Because of the Internet and the speed with which we can share information, more people will be able to find a way to recover their good health through alternative means.

Leukemia – Treatment Breakthroughs For Chronic Lymphocytic Leukemia

Recently released news from a U.S. pharmaceutical company stunned the market when they revealed that they had trialed a new drug that may help in the fight against chronic lymphocytic leukemia (CLL). About one month ago “Ibrutinib,” a new orally taken drug that is said to be different from traditional chemotherapy treatments by targeting specific processes and preventing tumor metastasis (spread) was announced.

It is said to work by binding to the B-cells (cells that produce antibodies) while not affecting the T-cells (cells that destroy invading pathogens [microorganisms] with perforins [a protein produced by killer cells of the immune system that causes disintegration] and granules [a small particle]).

When chemotherapy is given to a patient, usually it has the effect of causing the T-cells a great deal of damage. Because of this, the side-effects a cancer patient experiences can be quite severe. However, because Ibrutinib does not affect these vitally import T-cells, the adverse side-effects are significantly reduced.

Treatment for chronic lymphocytic leukemia is considered to be literally lifesaving. So such an important announcement has gathered an awful lot of interest from both researchers and physicians alike. Studies have been impressive, with the results astounding those involved.

One particular study showed where two different groups were trialed with Ibrutinib, one group (81% of patients) was given a 420 mg dose (considered a low dosage), and another group (40% of patients) was given a 840 mg dose (considered a high dosage), the results were unbelievable. These two groups accounted for 74% of all the CLL sufferers involved in the trials. Further more, the trials showed that nearly 90% of patients showed a 50% reduction in lymph nodes.

The trials carried out on the CLL patients themselves has their challenges, as chronic lymphocytic leukemia is in general a very difficult disease to treat at the best of times. Over 40% of patients involved in these trials who had previously been given at least three prior treatments involving chemotherapy and other drugs, had suffered a relapse. Other challenges were age, as over 20% of the patients were over 70 years old.

To sum this up, Ibrutinib showed, and is still showing amazing results, as nearly 80% of those who were trialed are still taking the drug today, and who are showing a 90% response rate. Over 13% of patients have been able to achieve a complete response, and a minority of 3% have been declared in remission and who will be continually monitored in the future. It certainly seems that Ibrutinib has a future!

What Is Chronic Lymphocytic Leukemia?

As blood gets pumped around the human body, it delivers both oxygen and nutrients to vital organs and cells, while at the same time removing the carbon dioxide and other waste in the process. Blood is made-up of trillions of microscopic cells that can be found in a watery liquid called plasma. These blood cells are broken down into three different types: red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes).

All three types of cells have a specific purpose within the body; however, when these cells become contaminated they cease to function correctly. White blood cells are created in bone marrow from stem cells, and are broken down into three different types. After their creation they are introduced into the blood circulatory and lymphatic system. Although part of the immune system and an important part in fighting off infection, they make-up for only about 1% of all cells that can be found in human blood.

When white blood cells become cancerous, the disease is called “leukemia.” Leukemia causes the bone marrow where white cells are created to produce abnormal cells. These same cells in turn cause healthy blood cells to be hampered by crowding them out and making it more difficult for the blood to do its job properly. Chronic lmphocytic leukemia (CLL) is where too many lymphocytes (white cells) are produced.

It is not uncommon for CLL to show no symptoms at all in a sufferer, and is only usually discovered after a routine check-up has been ordered relating to another illness. However, when symptoms do occur, they are generally the same as those that are associated with many other types of cancers: swelling (of the lymph nodes in the neck, under the arm in the armpit, the stomach and groin [this swelling is usually painless]), pain below the ribs (usually very painful [sometime a sense of fullness of the stomach may be experienced]), weight loss without a reason as to why (without diet or exercise), and a fever or infection.

Treatments may include chemotherapy, radiation therapy or targeted therapy where substances are used to attack cancerous cells without harming the healthy ones. These may include monoclonal antibodies (man-made immune system proteins), cancer vaccines (substances designed to trigger a response within the body that act against certain types of diseases), or non-specific immunotherapies (treatments designed to stimulate the immune system [man-made cytokines such as interleukins or interferons]).

Targeted drugs usually have less severe side-effects than traditional chemotherapy drugs and are a better option for the patient.

A bone marrow transplant may also be considered, sometimes offering a patient a better chance to be cured.